BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Shenzhen Ionova Life Sciences Co.\, Ltd. readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Shenzhen Ionova Life Sciences Co.
 \, Ltd.'s drugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07612891-9101@assetmemo.bio
DTSTAMP:20261121T005948Z
DTSTART;VALUE=DATE:20280204
DTEND;VALUE=DATE:20280205
SUMMARY:INV-6452: Phase 1/2 readout est. (NCT07612891)
DESCRIPTION:INV-6452\, phase 1/2\, HR+/HER2- Metastatic Breast Cancer.\nStu
 dy: A Study to Evaluate the Safety\, Tolerability\, Pharmacokinetics\, and
  Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone
  Receptor Positive\, Human Epidermal Growth Factor Receptor 2 Negative (HR
 +/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic 
 Solid Tumor\nEstimated primary completion: 4 February 2028. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/inv-6452#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07612891
URL:https://assetmemo.bio/drug/inv-6452#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07610798-2553@assetmemo.bio
DTSTAMP:20261121T005948Z
DTSTART;VALUE=DATE:20290531
DTEND;VALUE=DATE:20290601
SUMMARY:INV-8989: Phase 1/2 readout est. (NCT07610798)
DESCRIPTION:INV-8989\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy: A St
 udy to Evaluate the Safety\, Tolerability\, Pharmacokinetics\, and Prelimi
 nary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors
  Harboring KRAS G12D Mutations\nEstimated primary completion: May 2029. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/inv-8989#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07610798
URL:https://assetmemo.bio/drug/inv-8989#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
